Chronic methylphenidate administration in mice produces depressive-like behaviors and altered responses to fluoxetine

Synapse

Volumn 66, Issue 9, 2012, Pages 844-847

  Brookshire, Bethany R ^a   Jones, Sara R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Depressive like behaviour; Fluoxetine; Forced swim test; Locomotor activity; Methylphenidate

Indexed keywords

FLUOXETINE; METHYLPHENIDATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG DOSE INCREASE; DRUG EFFECT; DRUG MEGADOSE; FEMALE; FORCED SWIMMING TEST; IMMOBILIZATION; LATENT PERIOD; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSION; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; MALE; METHYLPHENIDATE; MICE; MICE, INBRED C57BL; NEUROPSYCHOLOGICAL TESTS;

EID: 84863489863     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21569     Document Type: Article

References (28)

1. Adriani W, Leo D, Greco D, Rea M, di Porzio U, Laviola G, Perrone-Capano C. 2006. Methylphenidate administration to adolescent rats determines plastic changes on reward-related behavior and striatal gene expression. Neuropsychopharmacology 31: 1946-1956.
2. Barr AM, Markou A, Phillips AG. 2002. A 'crash' course on psychostimulant withdrawal as a model of depression. Trends Pharmacol Sci 23: 475-482.
3. Biederman J, Spencer T. 2002. Methylphenidate in treatment of adults with Attention-Deficit/Hyperactivity Disorder. J Atten Disord 6 ( Suppl 1): S101-S107.
4. Bolanos CA, Barrot M, Berton O, Wallace-Black D, Nestler EJ. 2003. Methylphenidate treatment during pre- and periadolescence alters behavioral responses to emotional stimuli at adulthood. Biol Psychiatry 54: 1317-1329.
5. Bolanos CA, Willey MD, Maffeo ML, Powers KD, Kinka DW, Grausam KB, Henderson RP. 2008. Antidepressant treatment can normalize adult behavioral deficits induced by early-life exposure to methylphenidate. Biol Psychiatry 63: 309-316.
6. Brandon CL, Steiner H. 2003. Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum. Eur J Neurosci 18: 1584-1592.
7. Brandon CL, Marinelli M, Baker LK, White FJ. 2001. Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats. Neuropsychopharmacology 25: 651-661.
8. Brookshire BR, Jones, SR. 2009. Direct and indirect 5-HT receptor agonists produce gender-specific effects on locomotor and vertical activities in C57 BL/6J mice. Pharmacol. Biochem. Behav. 94: 194-203.
9. Carlezon WAJr, Mague SD, Andersen SL. 2003. Enduring behavioral effects of early exposure to methylphenidate in rats. Biol Psychiatry 54: 1330-1337.
10. Coetzee M, Kaminer Y, Morales A. 2002. Megadose intranasal methylphenidate (ritalin) abuse in adult attention deficit hyperactivity disorder. Subst Abus 23: 165-169.
11. Crowley JJ, Blendy JA, Lucki I. 2005. Strain-dependent antidepressant-like effects of citalopram in the mouse tail suspension test. Psychopharmacology 183: 257-264.
12. Davies HM, Hopper DW, Hansen T, Liu Q, Childers SR. 2004. Synthesis of methylphenidate analogues and their binding affinities at dopamine and serotonin transport sites. Bioorg Med Chem Lett. 14: 1799-1802.
13. Gatley SJ, Pan D, Chen R, Chaturvedi G, Ding YS. 1996. Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sci 58: 231-239.
14. Gatley SJ, Volkow ND, Gifford AN, Fowler JS, Dewey SL, Ding YS, Logan J. 1999. Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans. Psychopharmacology 146: 93-100.
15. Hoplight BJ, Vincow ES, Neumaier JF. 2007. Cocaine increases 5-HT1B mRNA in rat nucleus accumbens shell neurons. Neuropharmacology 52: 444-449.
16. Hoyer D, Clarke DE, Fozard JR, Hartig PR, Martin GR, Mylecharane EJ, Saxena PR, Humphrey PP. 1994. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 46: 157-203.
17. Klein-Schwartz W. 2002. Abuse and toxicity of methylphenidate. Curr Opin Pediatr 14: 219-223.
18. Kuczenski R, Segal DS. 1997. Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine. J Neurochem 68: 2032-2037.
19. Lucki I, Dalvi A, Mayorga AJ. 2001. Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice. Psychopharmacology 155: 315-322.
20. Markowitz JS, DeVane CL, Pestreich LK, Patrick KS, Muniz R. 2006. A comprehensive in vitro screening of d-, l-, and dl-threo-methylphenidate: an exploratory study. J Child Adolesc Psychopharmacol. 16: 687-698.
21. McCabe SE, Knight JR, Teter CJ, Wechsler H. 2005. Non-medical use of prescription stimulants among US college students: Prevalence and correlates from a national survey. Addiction 100: 96-106.
22. Moreau JL, Scherschlicht R, Jenck F, Martin JR. 1995. Chronic mild stress-induced anhedonia model of depression; sleep abnormalities and curative effects of electroshock treatment. Behav Pharmacol 6: 682-687.
23. Przegalinski E, Czepiel K, Nowak E, Dlaboga D, Filip M. 2003. Withdrawal from chronic cocaine up-regulates 5-HT1B receptors in the rat brain. Neurosci Lett 351: 169-172.
24. Teter CJ, McCabe SE, Boyd CJ, Guthrie SK. 2003. Illicit methylphenidate use in an undergraduate student sample: Prevalence and risk factors. Pharmacotherapy 23: 609-617.
25. Teter CJ, McCabe SE, LaGrange K, Cranford JA, Boyd CJ. 2006. Illicit use of specific prescription stimulants among college students: Prevalence, motives, and routes of administration. Pharmacotherapy 26: 1501-1510.
26. Valvassori SS, Frey BN, Martins MR, Reus GZ, Schimidtz F, Inacio CG, Kapczinski F, Quevedo J. 2007. Sensitization and cross-sensitization after chronic treatment with methylphenidate in adolescent Wistar rats. Behav Pharmacol 18: 205-212.
27. Willner P. 1997. The mesolimbic dopamine system as a target for rapid antidepressant action. Int Clin Psychopharmacol. 12: S7-S14.
28. Yang PB, Cuellar DOIII, Swann AC, Dafny N. 2010. Age and genetic strain differences in response to chronic methylphenidate administration. Behav Brain Res 218: 206-217.